Prophylactic and therapeutic implications of toll-like receptor ligands.
about
Pattern-recognition receptors and gastric cancerImmune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsThe Research Progress on Intestinal Stem Cells and Its Relationship with Intestinal Microbiota.Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.Cancer and the microbiome: potential applications as new tumor biomarker.Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer.Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells.Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities.Adjuvant immunotherapies as a novel approach to bacterial infections.Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic review.Toll like receptors: a new hope on the horizon to treat multiple sclerosis.Toll-like receptor signaling in parasitic infections.Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases.Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency.Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis.Signaling mechanism for Aspergillus fumigatus tolerance in corneal fibroblasts induced by LPS pretreatment.A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation.MyD88 knockout mice develop initial enlarged periapical lesions with increased numbers of neutrophils.Pru p 3-Epitope-based sublingual immunotherapy in a murine model for the treatment of peach allergy.
P2860
Q26991941-23ECDDDD-BC08-4A83-969B-C6AB2FF70F59Q28972540-9F3EE19D-69C9-43FC-B110-78756BD58DEDQ33715483-9196862F-6F12-40F7-84C4-7F7795AAE47DQ34698758-D843D566-C873-4679-8FBB-13392A234D16Q35161541-06921FBB-842D-4663-85AE-83612E310E05Q35508820-230132C2-601E-4981-8B0D-C832EB1DD221Q36711018-74D94E58-0B59-440F-8CB9-4E452D7D12ECQ37641651-7E2269C5-028E-4DB4-8486-5D9F29D9C8F9Q38053492-719B08B2-5C3B-483B-8EDC-99CBB23860AAQ38096056-D096C622-2A58-46B5-92A2-9571B576D13CQ38148590-592EA9D2-4781-4FDE-9433-71B96B0FAD6DQ38243754-DA437942-3297-4F16-82C7-120902191F4BQ38432017-609EA903-9607-416F-9435-553F2FDB6FC0Q38500621-9C12CD44-EC42-4557-B243-AF4470A37B7AQ38767112-F7E74ADD-B82F-4E8C-8E31-4B02CDD7F34CQ38881534-96374662-D9CA-4518-A4C1-3B277D52242DQ39094592-4F2D1A19-DBB2-442F-9391-D6C1ADE2B588Q42205220-8F43075B-2B03-40CF-BA9E-303EBBC5F4D0Q44846074-260B85EE-ABAD-43DA-96C3-0173097A3E73Q50957303-F6755C8A-298A-4A7E-B535-21F87053CC1F
P2860
Prophylactic and therapeutic implications of toll-like receptor ligands.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prophylactic and therapeutic implications of toll-like receptor ligands.
@en
Prophylactic and therapeutic implications of toll-like receptor ligands.
@nl
type
label
Prophylactic and therapeutic implications of toll-like receptor ligands.
@en
Prophylactic and therapeutic implications of toll-like receptor ligands.
@nl
prefLabel
Prophylactic and therapeutic implications of toll-like receptor ligands.
@en
Prophylactic and therapeutic implications of toll-like receptor ligands.
@nl
P2860
P356
P1476
Prophylactic and therapeutic implications of toll-like receptor ligands.
@en
P2093
Kiyoshi Takeda
Mona Hedayat
P2860
P304
P356
10.1002/MED.20214
P50
P577
2010-10-25T00:00:00Z